Diabetes: Plant-based insulin formulation may improve treatment
A plant-based formulation of insulin delivered orally may be a cheaper, better, less invasive alternative to current insulin production in the future, improving diabetes treatment.
Stay updated with breaking news from Translational Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A plant-based formulation of insulin delivered orally may be a cheaper, better, less invasive alternative to current insulin production in the future, improving diabetes treatment.
This time next week, the Boston Convention and Exhibition Center will be positively buzzing with a broad range of those in the pharmaceutical industry for the annual DIA global meeting.
Chronic stress is known to have a negative impact on cardiovascular health. Determining if stress affects heart health through changes in gut bacteria and if exercise can provide protection is the goal of a $4.3 million grant researchers at The Ohio State University Wexner Medical Center and College of Medicine received recently from the American Heart Association (AHA).
A new, affordable method of insulin delivery developed by Henry Daniell of the School of Dental Medicine lowers the risk of hypoglycemia when compared to current diabetes treatments.
NIH-funded study indicates substantial need to expand access to evidence-based treatment among young people.